This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $2,058,402 to The Regents of the University of California, San Francisco (UCSF) to adapt and evaluate a community-based intervention to increase respiratory syncytial virus (RSV) vaccine uptake among Latino older adults. The study aims to leverage UCSF's community partnership to adapt two intervention components - community health...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $400,000 to the University of California, Irvine to study the influence of social media, social networks, and misinformation on vaccine acceptance among Black and Latinx individuals. The study aims to: 1) identify the relationship between social media data and vaccine acceptance among Black and Latinx followers of...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $4,219,628 to Yale University to conduct a behavioral intervention study targeting the prevention of HIV-related comorbidities among Black and Latinx sexual minority men. The key objectives are to: 1) utilize formative research to modify the intervention to address social determinants of health impacting prevention of shared...
This $836,895 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year research study to develop and evaluate communication strategies to promote HIV vaccine and prevention uptake among young Black women in the Southern U.S. The project, led by researchers at Baylor College of Medicine, will use community-based participatory methods to co-create theory-based messaging, graphics, and videos to...
This Project Grant award of $200,000.00 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) supports a research project titled "Harnessing Data Science to Improve HIV Care Continuum Outcomes: A Hybrid Type 2 Trial Evaluating a Machine-Learning Algorithm-Based Implementation Strategy". The primary goal is to develop and evaluate an algorithm-driven implementation strategy for a Comprehensive Care Management and Care Coordination (CCM/CC)...
The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $793,275 aims to study the tradeoffs between the equal and equitable distribution of scarce health resources, such as vaccines, during times of scarcity. The research team at the University of Michigan, with a sub-award to Stanford University, will leverage a large randomized natural experiment to analyze inequities in vaccine uptake across dimensions of health, social vulnerability, and race,...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $1,164,930 to The RAND Corporation to study the impact of school-located vaccination (SLV) models on improving routine, influenza, and COVID-19 vaccination rates among school-aged children in Colorado, particularly for health disparity populations. The key products and services to be delivered include: Describing the SLV models...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $148,824 to the Research Foundation of the City University of New York (RFCUNY) over a 5-year period from August 2024 to July 2029. The goal of the research is to understand the clinical and social factors that impact HIV and COVID-19 outcomes among people with HIV (PWH), and to characterize how the COVID-19...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $534,242 to the New York Blood Center, Inc. to study immune and behavioral responses to seasonal COVID-19 vaccines in transgender women. The goal is to understand the impact of gender-affirming hormone therapy on immune responses and facilitate evidence-based uptake of COVID-19 vaccines within the transgender...
This federal Project Grant award of $2,065,719, provided by the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research), aims to develop and optimize a community-based behavioral intervention to increase COVID-19 and influenza vaccination rates among African American/Black and Latino (AABL) persons in New York.
The study, led by a collaborative team from New York University and the Northern Manhattan Improvement Corporation, will test the effects of four intervention components - nurse-led shared decision-making, a text message intervention, modest lottery prizes for vaccination, and peer navigation to vaccination appointments. The primary outcome is staying up-to-date with COVID-19 vaccination, with influenza vaccination as a secondary outcome. The project will use a multiphase optimization strategy to identify the most cost-effective combination of intervention components and prepare for rapid scaling of the optimized intervention by community-based and outpatient health organizations.